These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3585592)

  • 1. Duplicitous drugs: the history and recent status of look-alike drugs.
    Morgan JP; Wesson DR; Puder KS; Smith DE
    J Psychoactive Drugs; 1987; 19(1):21-31. PubMed ID: 3585592
    [No Abstract]   [Full Text] [Related]  

  • 2. Fake urine samples for drug analysis: hot, but not hot enough.
    Person NB; Ehrenkranz JR
    JAMA; 1988 Feb; 259(6):841. PubMed ID: 3336195
    [No Abstract]   [Full Text] [Related]  

  • 3. Restricting amphetamines. Wisconsin's success story.
    Treffert DA; Joranson D
    JAMA; 1981 Apr; 245(13):1336-8. PubMed ID: 7206134
    [No Abstract]   [Full Text] [Related]  

  • 4. CNS stimulants and the look-alike drugs.
    Lake CR; Quirk RS
    Psychiatr Clin North Am; 1984 Dec; 7(4):689-701. PubMed ID: 6151645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 8. Curbing drug abuse in Iowa: one response to a growing problem.
    Quinn KM
    Bull Narc; 1983; 35(2):95-101. PubMed ID: 6605171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulants and narcotic drugs.
    King P; Coleman JH
    Pediatr Clin North Am; 1987 Apr; 34(2):349-62. PubMed ID: 3550657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA takes action against firms in scandal over generic products.
    Pollner F
    Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736
    [No Abstract]   [Full Text] [Related]  

  • 11. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 12. Legalization of drugs.
    Taub N
    Del Med J; 1989 Nov; 61(11):637-8. PubMed ID: 2625174
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacy compounding: customizing prescription drugs.
    Nordenberg T
    FDA Consum; 2000; 34(4):11-2. PubMed ID: 11924628
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance Policy Guide on Chapter 4 Human Drugs: Section 460.200 Pharmacy Compounding.
    J Pain Palliat Care Pharmacother; 2003; 17(1):99-106. PubMed ID: 14640347
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary drugs of abuse.
    Giannini AJ; Price WA; Giannini MC
    Am Fam Physician; 1986 Mar; 33(3):207-16. PubMed ID: 2869670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advertising: when do hospitals become liable? Liability exposure is on the upswing.
    Memel SL
    Healthc Exec; 1988; 3(2):39-41. PubMed ID: 10302645
    [No Abstract]   [Full Text] [Related]  

  • 17. Diversion of prescription drugs to the black market: what the states are doing to curb the tide.
    Forgione DA; Neuenschwander P; Vermeer TE
    J Health Care Finance; 2001; 27(4):65-78. PubMed ID: 11434714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
    Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
    [No Abstract]   [Full Text] [Related]  

  • 20. Battles over compounding from bulk drugs move forward.
    Clark A
    J Am Vet Med Assoc; 2005 Jul; 227(1):9-10. PubMed ID: 16013529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.